D. Powell et al., DEXAMETHASONE STIMULATES EXPRESSION OF INSULIN-LIKE GROWTH-FACTOR BINDING PROTEIN-1 IN HEP G2 HUMAN HEPATOMA-CELLS, Growth regulation, 3(1), 1993, pp. 11-13
Insulin-like growth factor binding protein-1 (IGFBP-1) serum levels ar
e increased by glucocorticoids and glucagon, and are decreased by insu
lin; these effects seem to reflect changes in hepatic IGFBP-1 expressi
on. Human HEP G2 hepatoma cells respond to cAMP or insulin with stimul
ation or inhibition of IGFBP-1 expression, respectively; however, dexa
methasone alone does not stimulate IGFBP-1 expression. Studies present
ed here show that in the presence of cAMP and theophylline, nontransfe
cted HEP G2 cells respond to further addition of dexamethasone with a
approximately 70% rise in IGFBP-1 mRNA levels, and HEP G2 cells transf
ected with IGFBP-1 promoter constructs respond to further addition of
dexamethasone with a approximately 70% rise in IGFBP-1 protein levels
and a approximately 9-fold rise in IGFBP-1 promoter activity. The stim
ulatory effect of dexamethasone and cAMP, confered to the IGFBP-1 prom
oter between 357 and 103 base pairs 5' to the mRNA cap site, is inhibi
ted by insulin. Thus, the cis elements necessary to confer multihormon
al regulation of IGFBP-1 expression appear to reside in a short stretc
h of DNA just upstream from the IGFBP-1 transcription start site.